(Q34318349)

English

Selective SGLT2 inhibition by tofogliflozin reduces renal glucose reabsorption under hyperglycemic but not under hypo- or euglycemic conditions in rats.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Selective SGLT2 inhibition by tofogliflozin reduces renal glucose reabsorption under hyperglycemic but not under hypo- or euglycemic conditions in rats (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

based on heuristic

inferred from title

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Takumi Nagata

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Masanori Fukazawa

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Kiyofumi Honda

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Tatsuo Yata

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Mio Kawai

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Mizuki Yamane

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Naoaki Murao

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Koji Yamaguchi

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Motohiro Kato

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Tetsuya Mitsui

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Yoshiyuki Suzuki

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Sachiya Ikeda

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

18 December 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

304

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

E414-23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23249697%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Functional characterization of mouse sodium/glucose transporter type 3b

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

SGLT2 inhibition--a novel strategy for diabetes treatment

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

THE ACTION OF PHLORIZIN ON THE EXCRETION OF GLUCOSE, XYLOSE, SUCROSE, CREATININE AND UREA BY MAN.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Development and testing of a simple algorithm for a glucose clamp.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Comment on: Vila et al. B-type natriuretic peptide modulates ghrelin, hunger, and satiety in healthy men. Diabetes 2012;61:2592-2596.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium-glucose co-transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

A novel SGLT is expressed in the human kidney

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Why Do SGLT2 inhibitors inhibit only 30-50% of renal glucose reabsorption in humans?

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Discovery of tofogliflozin, a novel C-arylglucoside with an O-spiroketal ring system, as a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

The proximal tubule in the pathophysiology of the diabetic kidney

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

SGLT2 mediates glucose reabsorption in the early proximal tubule.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Biology of human sodium glucose transporters

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Pharmacokinetic and pharmacodynamic modeling of the effect of an sodium-glucose cotransporter inhibitor, phlorizin, on renal glucose transport in rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00545.2012

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34318349&oldid=1180002806"